Patients as Partners in Rare Disease Diagnosis and Research
- PMID: 34970107
- PMCID: PMC8686769
Patients as Partners in Rare Disease Diagnosis and Research
Abstract
There is great value in understanding the patient perspective in rare disease diagnosis and research, and in partnering actively with patients and their families throughout the process. Meaningful and respectful interaction between patients and researchers leads to learning on both sides, and ultimately, to better research outcomes. Researchers can help patients understand how research is conducted and what the latest advances and perceived gaps in research are, and patients, who have direct experience living with their health conditions, can impart to researchers what is most important to them. We describe our engagement with patients in the Undiagnosed Diseases Network (UDN) program, as well as the lessons we have learned to date. In the UDN, patients have been instrumental in bringing meaning to the work of clinicians and researchers, building patient communities, making the network aware of unmet patient needs, advocating for additional research funding, and disseminating UDN research findings. Although patient engagement in the UDN has already had a significant positive impact on our work, we continue to strive to involve patients earlier in the process, in the research design itself, and in addressing power dynamics that may arise between clinicians, researchers, and patients.
Keywords: Clinical Research; Patient Engagement; Rare Diseases.
Copyright ©2021, Yale Journal of Biology and Medicine.
Similar articles
-
Participation in a national diagnostic research study: assessing the patient experience.Orphanet J Rare Dis. 2023 Apr 10;18(1):73. doi: 10.1186/s13023-023-02695-5. Orphanet J Rare Dis. 2023. PMID: 37032333 Free PMC article.
-
Machine Learning of Patient Characteristics to Predict Admission Outcomes in the Undiagnosed Diseases Network.JAMA Netw Open. 2021 Feb 1;4(2):e2036220. doi: 10.1001/jamanetworkopen.2020.36220. JAMA Netw Open. 2021. PMID: 33630084 Free PMC article.
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
A rapid realist review of patient engagement in patient-oriented research and health care system impacts: part one.Res Involv Engagem. 2021 Oct 10;7(1):72. doi: 10.1186/s40900-021-00299-6. Res Involv Engagem. 2021. PMID: 34629118 Free PMC article. Review.
-
[Rare diseases and undiagnosed diseases: advances in neurodevelopment].Medicina (B Aires). 2023 Sep;83 Suppl 4:52-56. Medicina (B Aires). 2023. PMID: 37714123 Review. Spanish.
Cited by
-
A community-centric model for conference co-creation: the world conference on CDG for patients, families and professionals.Res Involv Engagem. 2024 Oct 23;10(1):107. doi: 10.1186/s40900-024-00641-8. Res Involv Engagem. 2024. PMID: 39443988 Free PMC article.
-
Knowledge and Attitudes of Clinical Trials among Patients with Rare Diseases and the Guardians in China.Ther Innov Regul Sci. 2024 Jan;58(1):53-62. doi: 10.1007/s43441-023-00571-9. Epub 2023 Sep 18. Ther Innov Regul Sci. 2024. PMID: 37721697
-
Together4RD position statement on collaboration between European reference networks and industry.Orphanet J Rare Dis. 2023 Sep 5;18(1):272. doi: 10.1186/s13023-023-02853-9. Orphanet J Rare Dis. 2023. PMID: 37670358 Free PMC article.
References
-
- Institute of Medicine. Scientific opportunities and public needs: Improving priority setting and public input at the National Institutes of Health. Washington (DC): The National Academies Press; 1998. - PubMed
-
- Council of Public Representatives. [Internet]. Cited 2021. October 4. https://www.nih.gov/institutes-nih/nih-office-director/office-communicat...
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases